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In the natural selection theory of antibody formation (1), Jerne proposed that 
the "antigen is solely a selective carrier of spontaneous circulating antibody to a 
system of cells which can reproduce the antibody." Although  proposed before 
the nature of the antigen-reactive cell was known, the hypothesis has proved to 
be remarkably accurate in its predictions. Central to the theory is the prediction 
that  natural  antibody  exists  prior  to  exposure  to  an  antigen,  and  that  the 
subsequent  response  is  composed  of antibody  that  is  identical  to  that  which 
interacts  with  the antigen  in the first place.  This study was undertaken  to test 
this prediction by examining the antigen-specific antibody response to preformed 
immune complexes. Specifically, we wished to determine whether the response 
to the antigen is influenced by allotypic or idiotypic determinants on the antibody 
used  to  form  the  immune  complex.  Our  approach  has  been  to  examine  the 
immunogenicity  of preformed  antigen/antibody  complexes  in  strains  of mice 
that  have  different  immunoglobulin  heavy chain  allotypes and  in  strains  that 
express either high or low levels of the relevant idiotype. 
In the network theory, Jerne suggested (2)  that  recognition  of self-idiotopes 
forms the basis of an immunoregulatory  network.  Indeed, there is a  great deal 
of evidence showing that immune responses can be regulated by anti-Id antibody 
or with  Id-specific T  cells.  However, in  most cells,  the anti-Id  responses were 
activated  under  nonphysiological  conditions,  such as repeated  injection  of Id- 
bearing  antibody  in  adjuvant  (3),  or  with  Id  artificially  coupled  to  cells  (4). 
Nevertheless, certain  investigators  have demonstrated  (5) that  the injection  of 
physiological concentrations of Id-bearing antibody caused a marked change in 
the  expression  of that  Id  in  a  subsequent  response  to  antigen.  Furthermore, 
Klaus (6) has shown that Id are highly immunogenic when presented in the form 
of antigen/antibody complexes. In spite of such findings, however, there remains 
skepticism of the importance of Id recognition in immune regulation (7, 8). 
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Previously (9), we examined the Id profile of the antibody response of BALB/c 
mice  to  immune  complexes  formed  in  antigen  excess.  The  complexes  were 
prepared  using the TEPC-15  myeloma protein and  the  PC-containing polysac- 
charide antigen (PnC). 1 The antibody response to this antigen in BALB/c mice 
is  dominated  by  the  T15  family  of  Id  that  are  expressed  on  the  TEPC-15 
myeloma protein (10,  11).  Our previous results (9) showed that the TEPC-15/ 
PnC complexes readily induced an antigen-specific PFC response that was equal 
to the response induced by free antigen; however, the Id profile of the response 
to the complex was more restricted than that of the response to the free antigen 
(9). Thus, the proportion of Id  PFC (as determined by plaque-inhibition  with 
the AB1-2 (11)anti-T15 mAb) was greater and more variable in individual mice 
immunized with PnC vs. those injected with TEPC-15/PnC complexes. 
The above results were obtained  using  BALB/c mice, a  strain  in  which  the 
response  to  PnC  is  dominated  by  a  major  or  recurrent  Id.  This  study  was 
undertaken to examine the response to TEPC-15/PnC complexes using mouse 
strains in which the T15 (AB1-2) Id is not dominant.  The results show that the 
response to TEPC-15/PnC complexes is under genetic control, and that respon- 
siveness to the complex correlates with the level of T 15 (AB 1-2) Id produced in 
response to immunization with free antigen (PnC). The results suggest that the 
antigen-specific response to immune  complexes is  Id-restricted and,  therefore, 
that the recognition of Id is important in regulating the immune response. 
Materials and Methods 
Animals.  Female  mice of the  following strains  were purchased  from The Jackson 
Laboratories,  Bar  Harbor,  ME:  BALB/cByJ,  C3H/HeJ,  C3H.SW,  and  C3H.OH, 
SEC/1ReJ,  A/J,  AKR/J,  CE/J,  C58/J,  and (BALB/cByJ X  C3H/HeJ)F~.  BALB.B and 
BALB.K mice were obtained from the Animal Resources Facility of Jewish Hospital of 
St. Louis. CB-20 mice were the generous gift of Dr. Jan Cerny of the University of Texas 
Medical branch at Galveston. All mice were used between the age of 8 and 14 wk. 
Antigens.  PnC  was  extracted  from Streptococcus  pneumoniae  R36a  as  described  by 
Anderson and  McCarty (12).  The concentration of PnC  was  based  on  the  weight of 
dialyzed, lyophilized material. Sheep and burro red blood cells (RBC) were obtained from 
Cleveland Scientific (Cleveland, OH). 
mAb and Myeloma Proteins.  The AB1-2 (anti-T15) hybridoma cell line was generously 
provided by Dr. John  Kearney, University of Alabama,  Birmingham, AL.  The AB1-2 
mAb and  the  TEPC-15  myeloma protein  were partially purified from ascites fluid as 
described elsewhere (13). 
Plaque-forming  Cell Assay.  A  microscope slide modification of the Jerne-Nordin he- 
molytic plaque assay was used (14). The PnC antigen spontaneously binds to RBC in the 
absence of phosphates. Thus, the RBC target cells were coated with PnC by incubating 1 
vol of burro RBC (washed three times in 0.85% saline) with 4 vol of PnC (0. I mg/ml in 
0.85% saline) at  37°C  for  1 h.  The coated RBC  were washed twice with saline, then 
resuspended to a  15% suspension in HBSS (Gibco Laboratories, Grand Island, NY). For 
the plaque assay,  the  following ingredients were added  to tubes containing 0.2  ml  of 
molten 0.5% agarose (Sea Plaque; FMC Maine Colloids, Rockland, ME) at 37°C:  RBC, 
0.04 ml of a  15% suspension; complement, 0.04 ml of a  1:3 dilution of guinea pig serum 
(preadsorbed with the target RBC); and spleen cells, 0.1  ml (various cell numbers).  For 
plaque-inhibition assays,  AB1-2 mAb was added at a final concentration of 1:300. The 
contents of the tubes were poured onto glass slides  (precoated with a 0.1%  solution of 
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agarose) and  incubated at  37°C for 2  h  in  a  sealed,  humid chamber.  The number of 
plaques was scored with  the aid of a  magnifying glass. The results  are expressed as the 
geometric mean of the number of PFC/spleen from 3-5 mice/group, assayed in duplicate. 
Assay for Serum Antibody and Id.  The serum IgM antibody response specific for PnC 
was measured by an ELISA as previously described (I 5). The serum concentration of IgM 
antibodies expressing the T15 Id defined by the AB1-2 mAb was determined by ELISA 
as follows:  Polyvinyl chloride 96-well  microtiter plates (Dynatech Laboratories, Alexan- 
dria,  VA) were coated with  50 ~1 of a  10 #g/ml solution (in  0.05  M Tris and  0.15  M 
saline,  pH 9.5) of the IgG mAb, AB1-2 (17),  which had been prepared from ascites fluid 
by ammonium sulfate precipitation.  After 4  h  at  37°C,  the  plates  were  blocked with 
0.05% gelatin in PBS, then washed three times with 0.15 M saline with 0.05% Tween 20 
(polyoxyethylene sorbitan  monolaurate;  Sigma  Chemical  Co.,  St.  Louis,  MO).  Serial 
fivefold dilutions of serum, in PBS-0.05% Tween with 0.05% gelatin (PBS-T), were made 
in consecutive wells of the coated plates in a final  volume of 0. I  ml, and the plates  were 
incubated overnight at 4°C.  A  T15 Id  + IgM mAb (41-H11) specific  for PnC that was 
prepared in this  laboratory was used as a standard.  After the second incubation period, 
the plates were washed three times with saline-Tween and then 50 #1 ofa 1:1,000 dilution 
of alkaline phosphatase-conjugated goat anti-mouse IgM (GAMIgM-AP) (Southern Bio- 
technology Associates,  Birmingham,  AL) was added  to each  well.  After an  overnight 
incubation at 4°C, the plates were washed three times with saline-Tween and then 50 ul 
of phosphatase substrate  (p-nitrophenyl phosphate,  1 mg/ml in  Tris-saline  with  1 mM 
magnesium chloride, pH 9.5) was added to each well and incubated for 30 min at room 
temperature. The reaction was stopped by adding 50 #1 of 3 M NaOH to each well. The 
optical density at  405  nm  in  each  well was determined  using an  MR580 MicroELISA 
Auto Reader  (Dynatech  Laboratories),  and  antibody  concentrations  were  determined 
relative to the standard using a computer program as previously described (15). 
Preparation oflmmune Complexes.  Initially,  complexes were prepared at various ratios 
to determine the equivalence zone. The complexes were incubated at 37°C for 30 min, 
and then at 4 °C overnight or until used. The complexes were centrifuged at ~800 g, and 
the supernatants were removed and tested for the presence of excess antigen or antibody. 
Excess antibody was detected by ELISA as described elsewhere (I 5), and excess antigen 
was detected by ELISA as follows:  plates were coated as described above with the IgA 
myeloma protein,  TEPC-15,  and  then  samples  to  be  tested  for  PnC  were  titrated  in 
consecutive wells of the coated plates.  An lgM anti-PnC mAb (41-H11) was then added 
at 1 t~g/well. Finally, GAMIgM-AP was added to each well, and the reaction was developed 
with p-nitrophenyl phosphate.  The antigen concentration of the unknown samples  was 
determined relative to a known standard. 
Once the equivalence zone bad been determined, complexes were prepared in antigen 
excess by adding a  10-fold excess of PnC to a standard amount of TEPC-15. Before use, 
the complexes were washed twice  with  0.85%  saline,  an aliquot was dissolved  in  0.1  N 
NaOH, and the protein concentration was determined as described previously (13). The 
amount of complex used was based on the concentration of protein in the complex. 
Results 
The  results  shown  in  Table  I  show  that  the  injection  of  TEPC-15/PnC 
complexes (formed  in  antigen  excess)  into  BALB/c mice  elicits  a  PnC-specific 
antibody response that is comparable to that induced with antigen alone. On the 
other band, immunization of C3H mice with TEPC-15/PnC complexes resulted 
in  a  weak  response  that  was  10-fold less  than  the  response  to  PnC alone.  The 
results also show that  the  PnC-specific response of BALB/c mice is dominated 
by the T15  (AB1-2) Id, whereas the  response of C3H  mice is  AB1-2-negative, 
confirming the results of others (11). Thus, the response to the complex appears 
to be genetically restricted. 
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TABLE  I 
C3H Mice Are Low Responders to TEPC-15/PnC Complexes Formed in Antigen Excess 
PnC-specific response 
Responder strain  Immunogen (~g)  Percent of  T15 Id  + 
PFC/spleen  control  PFC (%) 
BALB/c  PnC  (1)  15,690 (1,19)  Control  51 
TEPC-15/PnC  (10)  20,520 (1.30)  130  98 
C3H  PnC  ( 1  )  15,700  (1.19)  Control  <20 
TEPC-15/PnC  (1)  200 (1.62)  1  ND 
(10)  1,430 (1.20)  9  <20 
(100)  475 (1.26)  3  ND 
Mice from  each  strain  were  injected intraperitoneally with  either  1 tag of PnC  or with  various 
concentrations of TEPC-15/PnC complexes as indicated. 5 d later, the number of direct PFC was 
determined using PnC-coated burro RBC as target cells. The results are expressed as the geometric 
mean of the number of PFC/spleen with the standard error factor in parentheses. The percentage 
of PFC secreting the T15 idiotope defined by the AB1-2 mAb was determined by plaque inhibition. 
TABLE  II 
Responsiveness to TEPC-15/PnC Complexes Is Not Allotype Restricted 
Responder strain 
Genetic loci  PnC-specific response* 
Immunogen  T 15 Id  ÷ 
H-2  Igh  PFC/spleen  PFC (%) 
Exp.  1 
BALB/c 
CB-20 
d  a  PnC  11,755 (1.33)  92 
TEPC-15/PnC  7,027  (1.06)  99 
d  b  PnC  56,426 (1.29)  98 
TEPC-15/PnC  25,118 (1.34)  98 
Exp. 2 
CB-20  d  b  PnC  39,423 (1.23)  99 
TEPC-15/PnC  22,019 (1.37)  99 
* The number of direct PFC/spleen was determined as in Table 1, 5 d after the injection of 1 ~tg of 
PnC or 10 tag of TEPC-15/PnC complexes. In each experiment, the response of CB-20  mice to 
TEPC-15/PnC cornplexes is not significantly different from their response to PnC using Student's 
t test. 
to form the complex, we reasoned that the response might be allotype restricted. 
Thus, CB-20 mice (which are congenic with BALB/c at the lgh locus) were tested 
for responsiveness to PnC and to TEPC-15/PnC  complexes. The  results (Table 
II) demonstrate  that the CB-20 mice responded  almost as well to the complex as 
they did to free antigen.  Thus,  the response to the complex does not appear  to 
be  allotype-restricted.  Interestingly,  even  though  CB-20  mice  are  Igh  b,  their 
response  to both  PnC  and  TEPC-15/PnC  complexes  is dominated  by the  T15 
(AB1-2) Id. 
In further experiments, we wished to determine  whether responsiveness to the 
complexes was controlled by I-region genes in the  H-2 complex. Thus,  we used 
two H-2 congenic strains on the C3H background,  C3H.SW  and C3H-OH.  C3H 
mice are H-2 k, whereas the C3H.SW  strain is H-2 b, and the I-region of the C3H- 
OH  strain is of the d  haplotype, the  same as that of BALB/c  mice, The  results CAULFIELD  ET  AL.  79 
from Table III (Exps.  1 and 2) demonstrate that both congenic strains respond 
similarly to C3H mice;  i.e.  their response to TEPC-15/PnC  complexes is about 
10-fold less than their response to PnC alone. Based on these results, responsive- 
ness  to  the  complexes  is  apparently  not  determined  by  I-region  genes,  since 
BALB/c  and  C3H-OH  mice  share  the  same  I-region,  and  yet  the  former  are 
high  and  the  latter  are  low  responders  to  the  complex.  Interestingly,  both 
C3H.SW  and  C3H-OH  mice  are  T15  (AB1-2)  Id-,  suggesting  a  relationship 
between responsiveness to the complex and expression of the T 15 (ABI-2) Id. 
To  determine  whether  responsiveness  to  TEPC-15/PnC  complexes  is  con- 
trolled by other H-2 genes, BALB.K and BALB.B mice (which are congenic with 
BALB/c mice at the H-2 complex) were tested for their response to PnC and to 
TEPC-15/PnC complexes.  The results (Table III, Exp. 3) show that the overall 
response  to  PnC  appears  to  be  under  Ir  gene  control,  since  the  response  of 
BALB.K mice was -10-fold higher than the response of BALB.B mice. However, 
mice from each strain responded as well to the immune complex as they did to 
free antigen,  and in each case the response was dominated by the T15  (AB1-2) 
Id.  Taken  together,  the  results  from  Table  III  indicate  that responsiveness  to 
the TEPC-15/PnC complex is not controlled by genes in the H-2 complex. 
Further genetic  studies were performed to examine the serum IgM response 
to PnC and TEPC-15-PnC complexes.  13 strains comprising six allotypes were 
studied  to  determine  their  anti-PnC  antibody  response  to  immunization  with 
either PnC or TEPC-15/PnC  complexes.  The results (Fig.  1) confirm  the PFC 
data showing that responsiveness to the TEPC-15/PnC complex is not controlled 
by the  H-2  gene  complex.  Thus,  BALB.K  mice  are  high  responders,  whereas 
TABLE  III 
Responsiveness to the TEPC-15/PnC Complex Is Not Controlled by Genes in the H-2 Complex 
H-2 haplotype  PnC-specific  response 
Strain  Immunogen*  Percent of  T 15 
K  A~  A¢  E¢  J  E~  S  D  PFC/spleen  control  (ABI-2) 
Id  ÷ (%) 
Exp.  1 
BALB/cByJ  d  d  d  d  d  d  d  d  PnC  6,909 (1.89)  Control  92 
TEPC-I 5/PnC  4,589 (1.55)  66  96 
C3H/HeJ  k  k  k  k  k  k  k  k  PnC  10,014 (I.23)  Control  <20 
TEPC-I 5/PnC  812 (I .24)  8  ND 
C3H.SW  b  h  b  b  b  b  b  b  PnC  3,044 (2.45)  Control  <20 
TEPC- 15/PnC  199 (1.34)  7  ND 
Exp, 2 
BALB/cByJ  d  d  d  d  d  d  d  d  PnC  2,009 (2.73)  Control  93 
TEPC-I 5/PnC  1,974 (1.31)  98  87 
C3H/HeJ  k  k  k  k  k  k  k  k  PnC  6,651  (1.41)  Control  <20 
TEPC-I 5/PnC  210 (1.49)  3  ND 
C3H-OH  d  d  d  d  d  d  d  k  PnC  7,322 (1.58)  Control  <20 
TEPC-I 5/PnC  424 (1.72)  6  ND 
Exp. 3 
BALB.K 
BALB.B 
k  k  k  k  k  k  k  k  PnC  38,562 (1.30)  Control  98 
TEPC-I 5/PnC  26,688 (1.37)  69  97 
b  b  b  b  b  b  b  b  PnC  1,230 (2.05)  Control  95 
TEPC- 15/PnC  739 (1.47)  60  72 
* Mice  from  each  strain  were injected  with  either  PnC  or TEPC-15/PnC complexes,  and  the  number of direct  PFC/spleen  was 
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FIGURE  1.  Genetic control  of the  serum  antibody response to TEPC-IS/PnC complexes. 
Groups of at least four mice from each strain were immunized with PnC (0.2-1  #g) intraperi- 
toneally or with 10  ~zg of TEPC-15/PnC  complexes formed in antigen  excess. Sera were 
collected on day 5 and tested individually for IgM anti-PnC antibodies and for binding to anti- 
T15 (AB1-2) antibodies in a solid-phase ELISA as described in Materials and Methods. The 
results are expressed as the geometric mean of the serum antibody concentrations determined 
using a T15  + mAb (41-Hll) as a standard.  (0) Total lgM response to PnC; (I) total  IgM 
response to TEPC-15/PnC  complexes; (solid bar) TI 5 (AB1-2) Id  ÷ response to PnC; (striped 
bar) TI 5 (AB1-2) ld + response to TEPC-15/PnC  complexes. 
C3H mice are low responders, even though both strains are H-2  k. Furthermore, 
the results demonstrate that the serum response to the TEPC-15/PnC  complex 
is  not  allotype-restricted.  Thus,  CB-20  (Igh b)  and  A/J  (Igh e)  strains  are  high 
responders  to  complexes prepared  using TEPC-15,  a  BALB/c (Igh a) myeloma 
protein. 
Although  responsiveness to the  complex is not allotype-restricted, the results 
suggest  that  the  response  may be  controlled  by genes linked  to  the Igh  locus. 
Thus,  strains  that  are Igh j, Igh d,  and lgh  f  tend  to  be  low  responders,  whereas 
strains that are Igh a, Igh b, and Igh e are  high responders to the immune complex. 
(BALB/c  X  C3H)F1  mice gave an  intermediate  response to  the  complex.  The 
C58  strain  appears  to  be  an  exception,  since  it  is Igh a,  yet  tends  to  be  a  low 
responder; however the response of individual mice from this strain was variable, 
with  some  mice  yielding  a  relatively  high  response,  which  was  T15  (AB1-2)- 
positive (data not shown).  The SEC strain also appears to be an exception since 
it  has  been  classified  as Igh j  (20);  however,  the  allotype of this  strain  remains 
uncertain,  since  previous  studies  by  Herzenberg  et  al.  (21)  indicated  that  the 
SEC strain is Igh h. 
When the results from Fig.  1 were analyzed in more detail, it became apparent 
that the high-responder strains (to immunization with TEPC-15/PnC complexes) 
expressed high levels of T 15 (AB1-2) Id in their response to PnC, whereas low- 
responder strains produced relatively Tow leveTs of TI 5 in their response to PnC. CAULFIELD  ET  AL.  81 
Indeed, as shown in  Fig.  2,  there is a  very strong correlation between respon- 
siveness to the TEPC-15/PnC complex and the level of T15 Id produced in the 
response of each strain  to  PnC.  These results suggest that the genetic factors 
that control T 15 Id expression also control responsiveness to the TEPC-15/PnC 
complex. 
The results thus far are consistent with the concept that the response to TEPC- 
15/PnC  complexes is Id-restricted. This suggests that BALB/c mice should be 
low  responders  to  complexes formed using a  T15-antibody.  To  address  this 
question, we prepared a T15- PnC-specific mAb from C3H mice (which are low 
responders to the TEPC-15/PnC  complex). This antibody (79-14G6) was used 
to form complexes with PnC to test for immunogenicity in BALB/c mice. The 
C3H antibody (79-14G6)  is  IgM; therefore, control complexes were prepared 
using a  BALB/c IgM antibody (41-H11)  rather than using TEPC-15,  which is 
IgA. As shown in  Table IV, BALB/c mice gave a  good PnC-specific antibody 
response (8,290  PFC/spleen) to complexes formed with the BALB/c antibody, 
whereas they gave a low response (1,036 PFC/speen) to complexes formed with 
the C3H antibody. There are no reported allelic differences between BALB/c 
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FIGURE 2.  Correlation  between  TI5  Id  expression  and  responsiveness  to  TEPC-15/PnC 
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TABLE  IV 
Response of BALB/c Mice to Immune Complexes Formed with BALB/c 
(T15 ÷) vs. C3H (T15-) Antibodies 
PnC-specific 
Immune complex  ldiotype  PFC/spleen 
41 -H 11/PnC (BALB/c)  T 15 +  8,290 ( 1.45) 
79-1466/PnC (C3H)  T15-  1,036 (1.39) 
BALB/c mice were  injected  intraperitoneally  with  30  t~g of either 41- 
H 1 I/PnC or 79-14G6/PnC immune complexes formed at equivalence. 5 
d  later,  the  number  of PnC-specific  PFC/spleen  was  determined  as  in 
Table I. 
and C3H IgM antibodies (both are Igh-6a);  therefore, these results support our 
conclusion that the response to certain immune complexes is Id-restricted. 
Discussion 
The results of these studies indicate that the antigen-specific response of mice 
to TEPC-15/PnC immune complexes is genetically controlled, i.e., the response 
of certain strains to the complex is 10-folcl less than their response to free antigen. 
Since the TEPC-15 myeloma was derived from BALB/c mice, and since BALB/c 
but not C3H mice were responders to the complex, we attempted to determine 
whether responsiveness was allotype-restricted by using CB-20 mice, which are 
congenic with  BALB/c mice  at  the Igh  locus.  The  results  showed that  CB-20 
(Igh b) mice responded as well or better than BALB/c (Igh ~) mice. Thus, respon- 
siveness to the complex does not appear to be restricted to strains expressing the 
same allotype as BALB/c. Furthermore,  the antibody used to form the complex 
(TEPC-15)  is  IgA,  whereas  the  response  that  we  measured  is  IgM.  Taken 
together,  the results suggest that responsiveness to the TEPC-15/PnC  complex 
is not determined by immunoglobulin heavy chain constant region gene products. 
The response to many antigens is controlled by genes located in the I region 
of the  MHC (16-18).  Therefore,  determination  of whether  the  I  region  con- 
trolled the response to TEPC-15/PnC  complexes seemed reasonable. Thus, we 
determined  the  response  of H-2  congenic  CBH  mice  to  PnC  and  to  TEPC- 
15/PnC complexes. The results showed that both C3H.SW (H-2  b) and C3H-OH 
(which has  the d  haplotype in  the  I  region) are similar  to C3H (H-2  k) mice in 
that  they  are  low responders  to  the  complex.  In  spite  of sharing  the  same  I 
region genes, C3H-OH mice are low responders whereas BALB/c mice are high 
responders to the TEPC-15/PnC complexes. Thus, the I region does not appear 
to control responsiveness to the complex. 
In a  reciprocal experiment,  we tested the response of BALB.B and BALB.K 
mice (which are congenic with BALB/c at the H-2 complex) for their response 
to  PnC  and  TEPC-15/PnC  complexes.  Interestingly,  the  results  showed  that 
BALB.K mice gave a  response to free PnC  that  was -10-fold higher  than  the 
response  of  BALB.B  mice,  whereas  BALB/c  mice  yielded  an  intermediate 
response.  Thus,  the  antibody  response  to  PnC  appears  to  be  under  Ir  gene 
control.  Nevertheless, in each strain,  the response to the complex was approxi- 
mately the same as the response to the free antigen,  indicating  that  H-2 genes CAULFIELD ET  AL.  83 
were not controlling responsiveness to the immune complex. The antigen  used 
in  these studies  (PnC)  is a  soluble extract  from S. pneumoniae  R36a;  it differs 
from a  vaccine prepared  from whole bacteria,  which is highly immunogenic in 
BALB.B mice (J. Cerny, personal communication). 
Responsiveness to the antigen/antibody complex appears to correlate with the 
ability of a  mouse strain  to produce high  levels of antibody that  expresses the 
same idiotype as that  used to form the complex. Thus,  strains  such as BALB/c 
and CB-20, which express high levels of the T15 (AB 1-2) Id are high responders 
to TEPC-15/PnC  complexes, whereas strains such as C3H, C3H.SW, and C3H- 
OH (which express low levels of the T15 [AB1-2] Id) are low responders to the 
complex. When the results from  13 strains were examined (Fig.  2),  there was a 
very strong correlation  between the  level of response to the complex and  the 
level of T 15 (AB 1-2) Id produced in response to PnC. These results suggest that 
the  same genetic elements  that  control  the  expression  of the  T15  (AB1-2) Id 
may also control the response to TEPC-15/PnC complexes. 
Claflin  (19) has  shown  that  mice  from a  large  variety of strains  express the 
T15  Id,  as  defined  by an  A/J  (mouse)  anti-T15  sera;  however,  three  strains 
C3H/HeJ, CBA/J, and PL/J (which are all Igh  j) were shown to express low levels 
of this Id. In contrast, the SEC strain,  which has been classified as Igh  j (20), was 
found  to  express  high  levels  of the  T15  idiotype  (19),  suggesting  that  the 
expression of T15 is not controlled by allotype-linked genes. However, classifi- 
cation of the SEC strain as Igh j is questionable, since Herzenberg et al. (21) had 
previously determined  this  strain  to be Igh h.  In  other studies,  Sher and  Cohn 
(22) examined  the strain  distribution  of the S107  Id (which is identical  to the 
T15  Id examined  herein)  using a  conventional  anti-Id  antiserum  prepared  in 
CE/J mice. Their results suggested that the expression of the S 107 Id is controlled 
by multiple factors, including  Igh-linked  genes and  genes of the H-2 complex. 
Our  current  results,  found  using  the  anti-T15  mAb  AB1-2  (11),  favor  the 
conclusion  that  the  expression  of the  T15  Id  is  controlled  by ailotype-linked 
genes. Thus, responsiveness to the complex (which is correlated with the expres- 
sion of the T 15 Id) also appears to be controlled by allotype-linked genes. 
The apparent requirement for Id recognition in the response to TEPC-15/PnC 
complexes leads us to suggest that the response is dependent on Id-specific helper 
cells. Indeed,  we have preliminary  results demonstrating  that athymic BALB/c 
nude mice are low responders to TEPC-15 PnC complexes (M. Caulfield and D. 
Isaak, unpublished observation), indicating that responsiveness to the complex is 
T-dependent. The putative Id-specific helper T  cells could interact directly with 
B cells via the Id expressed on surface immunoglobulin  molecules, resulting in 
the selective stimulation of an Id  + response. Alternatively, the immune complex 
could serve as a bridge to link Id-specific T  cells with antigen-specific B cells. In 
the second case, the response to the complex could be composed of a mixture of 
Id ÷ and Id- antibodies.  Indeed, we have observed (Fig.  1) that  the response of 
several strains to TEPC-15/PnC  complexes is not completely dominated by the 
T15 (AB1-2) Id, suggesting that T15- B cells are being triggered.  This second 
possibility suggests that Id-specific helper T  ceils could stimulate Id- B cells when 
the two cells were linked by the appropriate antigen/antibody bridge. This would 
be analogous  to the  interaction  of carrier-specific  helper  T  cells with  hapten- 84  GENETICALLY  RESTRICTED  RESPONSE  TO  IMMUNE  COMPLEXES  IN  VIVO 
specific B cells via a  hapten-carrier conjugate (23) in which both Id  + and Id- 
antibodies would be induced. In support of the above argument, Klaus (24) has 
presented evidence for the activation ofanti-Id antibody through the cooperation 
of antigen-specific T  cells  and  Id-specific  B  cells  mediated through  immune 
complexes. Furthermore, we previously showed (9) that the T15 (AB1-2) Id is 
exposed in  the TEPC-15/PnC  complexes, since anti-Id antibody binds  to  the 
complexes. Presumably, the Id (in the complex) could also be recognized by Id- 
specific helper T  cells. 
The results shown here may have some relevance to the phenomenon of Id 
matching in  the  response  to  PC-KLH  described by  Bottomly et al.  (25,  26). 
These  investigators  showed  that  carrier-primed T  cells  could  induce  an  Id- 
dominated response in  recipient mice only if both  the T  cell donors and the 
recipient mice were Id  +. These results were interpreted to suggest the existence 
of a  helper T  cell population  that recognizes both antigen and Id. Our results 
suggest a  mechanism whereby two separate populations of helper T  ceils, one 
carrier-specific and the other Id-specific, could be responsible for the Id-matching 
phenomenon. Thus, we suggest that the PC-KLH antigen (employed by Bottomly 
et al.) could form complexes with Id  + antibody when injected into Id  + recipients, 
thereby allowing Id-specific helper cells to interact with Id  + B cells and carrier- 
specific T  cells. Id- recipient mice could not form Id  + immune complexes, and 
therefore would not trigger an Id-dominated response. Support for this notion 
was provided by Woodland and Cantor (27), who showed that Id-specific helper 
T  cells were required (in addition  to carrier-specific helper cells)  for optimal 
production of antibody to hapten-carrier conjugates. 
Our finding that the antigen-specific response to the TEPC-15/PnC complex 
correlates  with  the  relative  dominance of the  T15  (AB1-2)  Id  suggests  that 
preexisting Id-specific regulatory mechanisms control the response to  the im- 
mune complex. Thus, presentation of antigen in the context of Id (i.e., in the 
form of an immune complex) restricts the response to the antigen. Therefore, 
our  results  strongly  indicate  that  the  recognition  of self-Id  is  important  in 
controlling the immune response. This information adds further support to the 
network hypothesis (2). 
Summary 
The primary antigen-specific antibody response of various strains of mice to 
TEPC-15/PnC  immune complexes has  been  examined.  We  found  that  both 
BALB/c and C3H  mice were good responders to the  PnC antigen; however, 
C3H mice were low responders, whereas BALB/c mice were high responders to 
the TEPC-15/PnC complexeS. Using congenic strains on the C3H and BALB/c 
background, we have shown that the response to the complexes is not restricted 
by gene products of the H-2 complex or by the Igh (allotype) locus. However, 
responsiveness may be controlled by genes linked to the Igh locus, since we have 
shown that strains that are Igh  ), IgU, and Ighfare low responders, whereas strains 
that  are  Igh ~,  Igh b,  and  Igh e are  high  responders  to  the  immune  complex. 
Moreover, responsiveness correlates with the expression of the T15 Id as mea- 
sured using the anti-T15  monoclonal antibody,  AB1-2.  Thus,  strains  such  as 
BALB/c, BALB.B, BALB.K, and CB-20, which express high levels ofT15 (AB1- CAULFIELD  ET  AL.  85 
2)  Id  in  their  PFC  response  to  PnC  are  relatively bigh  responders  to  TEPC- 
15/PnC complexes, whereas  C3H,  C3H.SW,  and C3H-OH,  whicb express low 
levels of the T15 (AB1-2) Id, are low responders to the complexes. Finally, we 
found that  BALB/c mice are high responders to complexes formed with TI5 + 
antibodies,  whereas they are  low responders to complexes formed using T15- 
antibodies. The results suggest that the antigen-specific response to these immune 
complexes is Id-restricted. 
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